Logotype for thyssenkrupp nucera AG & Co

thyssenkrupp nucera (NCH2) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for thyssenkrupp nucera AG & Co

Q2 2026 earnings summary

26 May, 2026

Executive summary

  • Q2 order intake surged to EUR 316 million, nearly quadrupling year-over-year, driven by major green hydrogen and chlor-alkali projects, with order backlog rising to EUR 732 million by March 2026.

  • Major new contracts include a 300 MW electrolyzer in Spain, a 260 MW FEED study in India, and a record chlor-alkali order in the Middle East.

  • Innovative offerings launched, including a 360-degree lifecycle service portfolio and a 120 MW plug-and-play electrolyzer system.

  • Quarterly financials were significantly impacted by one-time project costs, special items, and a contract termination in green hydrogen, but these are not expected to recur in the second half.

  • Strategic cost containment and efficiency programs launched to address market softness and improve competitiveness.

Financial highlights

  • Q2 order intake reached EUR 316 million (+279% YoY), with green hydrogen at EUR 176 million and chlor-alkali at EUR 140 million; order backlog at EUR 732 million.

  • Q2 sales declined 77% year-on-year to EUR 50 million, mainly due to one-time effects and project-specific cost overruns in green hydrogen; 6M sales at EUR 197 million (-59% YoY).

  • Q2 EBIT was EUR -65 million (vs. EUR -4 million prior year), driven by EUR 78 million EBIT loss in green hydrogen; 6M EBIT at EUR -69 million.

  • Q2 net income was EUR -64 million; EPS at EUR -0.50; 6M net income at EUR -66 million, EPS at EUR -0.53.

  • Free cash flow for 6M was EUR 3 million; Q2 free cash flow improved to EUR 9 million; net financial assets stable at EUR 655 million.

Outlook and guidance

  • Full-year 2025/26 order intake expected at EUR 550–850 million, sales at EUR 450–550 million, and EBIT at EUR -80 to -30 million.

  • Green hydrogen segment sales expected at EUR 120–170 million, EBIT at EUR -125 to -90 million; chlor-alkali sales at EUR 320–400 million, EBIT at EUR 45–65 million.

  • One-time effects from green hydrogen will impact this year’s results, but operational performance and guidance remain sound.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more